Products Siponimod was approved in film-coated tablet form in the United States in 2019 and in many countries in 2020 (Mayzent). Structure and properties Siponimod (C29H35F3N2O3, Mr = 516.6 g/mol) is present in the drug as a 2:1 co-crystal with the fumaric acid and as a white powder. The drug was developed starting from fingolimod, … Siponimod
Products Pomalidomide is commercially available in the form of hard capsules (Imnovid). It has been approved in many countries since 2014. It has been registered in the EU and the United States since 2013. Structure and properties Pomalidomide (C13H11N3O4, Mr = 273.2 g/mol) is an amino derivative of thalidomide and a racemate. It is also … Pomalidomide
Products is commercially available in many countries in the form of capsules and as powder in sachets (Perenterol) and has been approved since 1990. Perenterol travel has been registered and approved for the treatment of traveler’s diarrhea since 2010. In Europe, the fungus has been used as a probiotic since the 1950s. Structure and properties … Saccharomyces Boulardii
Products Cladribine was approved for the treatment of multiple sclerosis in the EU in 2017 and in the United States and many countries in 2019 in tablet form (Mavenclad). Cladribine has also been commercially available as an infusion and injection solution in many countries since 1998 (Litak). This article relates to MS therapy. Structure and … Cladribine
